Burch colposuspension decreases postop SUI
Adding Burch colposuspension to abdominal sacrocolpopexy for the treatment of pelvic-organ prolapse approximately halves the incidence of postoperative stress urinary incontinence (SUI) in women who do not have SUI preoperatively and does so without increasing other lower urinary tract symptoms, according to the results of a randomized controlled trial.
Adding Burch colposuspension to abdominal sacrocolpopexy for the treatment of pelvic-organ prolapse approximately halves the incidence of postoperative stress urinary incontinence (SUI) in women who do not have SUI preoperatively and does so without increasing other lower urinary tract symptoms, according to the results of a randomized controlled trial.
Researchers included 322 women in the study. Three months after surgery, 23.8% of the women receiving the Burch procedure and 44.1% of the women in the control group had SUI (P<0.001). Additionally, those in the control group were four times more likely than those in the Burch group to report bothersome symptoms surrounding the condition (24.5% vs. 6.1%; P<0.001). Neither group was more likely to develop urge incontinence.
Brubaker L, Cundiff GW, Fine P, et al. Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med. 2006;354:1557-1566.
Multicomponent intervention boosts quality of life in overactive bladder patients
March 15th 2024A recent study reveals the efficacy of a cognitive behavior therapy program, showcasing significant improvements in health-related quality of life among women grappling with moderate to severe overactive bladder.
Read More
Optimizing pain management post urogynecologic surgery with restrictive opioid protocol
March 14th 2024A recent study suggests that restrictive opioid prescribing protocols post-urogynecologic surgery are as effective as standard protocols, emphasizing the importance of multimodal analgesia and outpatient follow-up for patient satisfaction.
Read More
Study finds no increased stress urinary incontinence recurrence risk from childbirth
March 11th 2024A recent meta-analysis challenged common clinical assumptions, finding no increased risk of stress urinary incontinence recurrence or need for reoperation after subsequent pregnancy and childbirth following a midurethral sling procedure.
Read More
Cefepime–Taniborbactam outperforms meropenem in treating complicated UTI
February 15th 2024A recent study demonstrated the superior efficacy of cefepime–taniborbactam over meropenem for managing complicated urinary tract infections, suggesting a promising treatment option amid rising antibiotic resistance challenges.
Read More
